Showing results (91-100 of 16,794) with videos related to
Sort By:
Pageof 1,680
British Journal of Haematology|October 1, 2010
The class-I HDAC inhibitor MGCD0103 induces apoptosis in Hodgkin lymphoma cell lines and synergizes with proteasome inhibitors by an HDAC6-independent mechanismDaniela Buglio, Vidya Mamidipudi, Noor M Khaskhely, et al.British Journal of Haematology|October 1, 2010
Weekly versus twice weekly bortezomib given in conjunction with rituximab, in patients with recurrent follicular lymphoma, mantle cell lymphoma and Waldenström macroglobulinaemiaAgathoclis Agathocleous, Ama Rohatiner, Simon Rule, et al.British Journal of Haematology|July 20, 2010
A recombinant trispecific single-chain Fv derivative directed against CD123 and CD33 mediates effective elimination of acute myeloid leukaemia cells by dual targetingMarkus Kügler, Christoph Stein, Christian Kellner, et al.British Journal of Haematology|July 15, 2010
IL1RN VNTR and IL2-330 polymorphic genes are independently associated with chronic immune thrombocytopeniaAndreia Maria Camargos Rocha, Cláudia De Souza, Gifone Aguiar Rocha, et al.British Journal of Haematology|July 16, 2010
Advances in understanding the aetiology of atypical Haemolytic Uraemic SyndromePilar Sánchez-Corral, Marta MelgosaBritish Journal of Haematology|August 13, 2010
Plasma cell leukaemia and other aggressive plasma cell malignanciesTaimur Sher, Kena C Miller, George Deeb, et al.British Journal of Haematology|July 13, 2010
Optimizing dendritic cell-based immunotherapy in multiple myeloma: intranodal injections of idiotype-pulsed CD40 ligand-matured vaccines led to induction of type-1 and cytotoxic T-cell immune responses in patientsQing Yi, Susann Szmania, John Freeman, et al.British Journal of Haematology|August 27, 2010
Primary central nervous system lymphoma in the elderly: a multicentre retrospective analysisMascha Schuurmans, Jacoline E C Bromberg, Jeanette Doorduijn, et al.British Journal of Haematology|August 27, 2010
Common occurrence of monoclonal B-cell lymphocytosis among members of high-risk CLL familiesLynn R Goldin, Mark C Lanasa, Susan L Slager, et al.Pageof 1,680